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Abstract
Objective. The impairment of glycemic control can induce limited joint mobility even in young 
type 1 diabetic (T1DM) patients. The aims of this study were to verify the presence of ankle 
joint mobility (AJM) deficits in young T1DM subjects and define a mathematical model of dia-
betes mellitus long-term effects on AJM. 
Methods. AJM was evaluated using an inclinometer in 37 patients and 53 healthy, sex- BMI- and 
age-matched controls. To set up the mathematical model, we assumed that reduced metabolic 
control affects AJM according to a lognormal function: requiring some time for development 
of a reduction of joint mobility, which then persists for a long period, before fading out over 
time (if glycemic control has been recovered). A non-linear optimization determined the model 
parameters to achieve the best fit for a series of patients. 
Results. Both plantar and dorsiflexion AJM was significantly lower in diabetic subjects than in 
controls (plantarflexion: 28.5°±7.5 vs 35.2°±6.5; dorsiflexion: 93.9°±16.0 vs 104.7±12.8; p<0.01). 
The defined model approximates the experimental data with good accuracy; after optimization, 
the lognormal curve obtained is in line with empirical estimates: lack of glycemic control needs 
to persist for at least a few months before producing a significant effect, that lasts up until one 
year. The fitting procedure indicated the optimal solution is p = (37; 30; 3:5; 6:7; 137); thus, the 
optimal _im(t) corresponds to the curve reported.
Conclusion. AJM was significantly reduced in young T1DM patients. The mathematical model 
represents the experimental data accurately. 
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Introduction
Diabetes mellitus (DM) is a metabolic disorder which has become one of the main 
global public health issues. It is estimated that almost 600 million of people in 2035 
will be affected by DM due to its progressive increase (Guariguata et al., 2014; Lipsky 
et al., 2015).
Several epidemiological studies have shown that, even if there are significant 
regional differences, the incidence of type 1 diabetes (T1DM) has increased by about 
2-5% over the last few years. Thus, the number of young patients affected by T1DM 
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is increasing, representing about 5-10% of the total number of patients (Borchers et 
al., 2010; Mahaas et al., 2010; Guariguata et al., 2014).
Despite recent advances in patient care beginning at the pediatric age, diabetic 
patients may develop some chronic complications during their lifetime which are 
closely correlated with the quality of the metabolic control they maintain (Lindsay et 
al., 2005; Forbes and Cooper, 2013).
Some studies have reported that in young T1DM subjects, even if the incidence of 
limited joint mobility (LJM) shows a significant increase during the first years after 
disease onset, deterioration can be slower in adulthood. Therefore, the maximum 
prevalence of LJM is about 65% in subjects living with diabetes for longer than 30 
years (Infante et al., 2001; Lindsay et al., 2005; Francia et al., 2015a).
Regular monitoring of a DM patient’s condition is thus required, in order to pro-
vide early intervention. Joint abnormalities are one of the chronic diabetes-induced 
complications. The presence of stiff hand syndrome was first described by Lundbeack 
in the middle of the last century in adults and then by Grgic (1976) and Rosenbloom 
et al. (1981) in young patients with T1DM. Rosenbloom et al. (1981) published several 
studies reporting for the first time the prevalence of joint deficits, including those at 
the ankle, in young patients with T1DM and thus introducing the definition of lim-
ited joint mobility. 
It has been further confirmed that both adults and young patients with T1DM 
can have a significant reduction of joint mobility at the ankle level (Francia et al., 
2015a,b). The ankle joint has been extensively studied for the last 40 years in diabetic 
patients because of its important role in walking and because it is a distal joint which 
is particularly affected by diabetes (Mueller et al., 1989, 1995; Francia et al., 2014, 
2015b). LJM is particularly dreaded as a major risk factor for the development of 
foot ulcers and for its possible correlation with other chronic complications induced 
by diabetes (e.g. vascular disease). Several studies have reported the relationship 
between joint mobility and other dysfunctions associated with diabetes in young 
T1DM patients: delay in sexual maturation, growth alterations, and early microvas-
cular impairments such as retinopathy or nephropathy (Rosenbloom et al., 1981, 2015; 
Campbell et al., 1985; Zimny et al. 2004; Amin et al., 2005).
Factors predisposing to LJM occur from disease onset, and progressively worsen 
during its development (Abate et al., 2011; Rosenbloom et al., 2015). The main bio-
chemical abnormality in DM patients’ joint tissue is an excess of non-enzymatic 
glycosylation of collagen, with the production of advanced glycation and products 
(AGEs), which, in turn, lead to an increase in collagen cross-links. The increase in 
inter- and intra-molecular crosslinking of collagen fibers alters, in turn, the mechani-
cal properties of these tissues, resulting in reduced elasticity and tensile strength 
which can cause mechanical stiffness (deGrot, 2004; Browlee, 2005; Snedeker and 
Gautieri, 2014). This alteration may negatively affect static and dynamic posture, 
progressively reducing the quality of movement. In turn, these effects may further 
induce anomalies in the patient’s lifestyle (Mueller et al., 1989; Zimny et al., 2004; 
Francia et al., 2014).
However, no clear relationship has been identified between impaired metabolic 
control and joint mobility nor is the effect on joint mobility of impaired metabolic 
control over time understood. 
The aims of this study were to verify the presence of both plantar and dorsiflex-
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ion AJM deficit in young T1DM patients and to develop a mathematical model that 
would help understand the relationship between the level and duration of impaired 
metabolic control and the reduction in joint mobility. We believe that what we report 
can improve understanding of DM patients’ overall condition, the disease effects on 
some tissues and functional skills as well as the prevention of physical and postural 
impairments.
Patients and methods
Patients attending the Meyer Children’s Hospital in Florence, Italy, were consecu-
tively enrolled for evaluation of plantar and dorsal flexion AJM by means of an incli-
nometer (Fabrication Enterprises Inc, White Plains, NY, USA) following the procedure 
reported in previous articles (Francia et al., 2015a,b, 2017).
A total of 37 patients with type 1 diabetes, 22 males and 15 females, were evalu-
ated and compared with 53 healthy, age-, BMI- and sex-matched controls. Patients 
and controls ranged in age from 9 to 21 years. The main characteristics of the study 
participants are shown in Table 1. Patients with orthopedic and/or surgical foot com-
plications were excluded. Data on age, sex, weight, height, body mass index (BMI, 
expressed as body weight in kilograms divided by height in meters squared, kg/m2) 
diabetes duration, and presence of neuropathy were collected. The physical examina-
tion included foot inspection and evaluation of deformity. Hemoglobin A1c (HbA1c) 
was measured at baseline by high performance liquid chromatography (HPLC). 
Measured mobility was associated with previous measurements of glycosylated 
hemoglobin, extracted from the patient’s health record, as required by the clinical 
protocol: measured every three months from the time of disease diagnosis. 
It should be mentioned that HbA1c measurements reflect the overall degree of 
metabolic control over a period of 3 months (Saudek and Brick, 2009), thus, a vector 
of up to 20 values of glycosylated hemoglobin per patient was associated with mobil-
ity measurement. 
All participants and parents or caregivers of the young subjects were informed 
about the study purpose and its experimental procedures before collecting written 
informed consent for enrollment in the study. The protocol and the consent forms 
were approved by the Ethics Committee of the Meyer Children’s Hospital in Flor-
ence. The study was performed in accordance with the Helsinki declaration.
Determination of ankle joint mobility
To measure ankle range of motion (ROM), the patient was lying supine, with the 
subtalar joint in neutral position and the feet extending over the edge of the couch. 
The knee, corresponding to the evaluated ankle, was extended and positioned over a 
rigid support, 5 cm high.
The peak of plantar and dorsiflexion ROM was determined after marking the fifth 
metatarsal bone with a dermographic pen and positioning the inclinometer along 
the diaphysis of the bone, with one extremity positioned on the distal condylus. All 
measurements were performed by the same observer, who recorded the mean of 
three consecutive readings.
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Mathematical model
The relationship between impaired metabolic control and measured mobility 
is described by a linear model. The model assumes that mobility is decreased, with 
respect to the physiological value, of a quantity linearly dependent from the entity 
of impairment of metabolic control with respect to the optimal value. For simplicity’s 
sake, the model assumes that the effects of impaired control over time undergo a lin-
ear superimposition. In the temporal dimension, the impaired control causes a tem-
porary decrease in mobility, represented by lognormal curve.
Summarizing, the mobility of a given subject p is expressed as:
𝑚𝑚"(𝑡𝑡) = 𝑚𝑚0 −(𝑚𝑚) (𝑡𝑡) 
 
where m0 is baseline mobility, and mi is the reduction in mobility caused by impaired 
control g(ti) at the time instant ti. This function is, in turn, expressed as:
𝑚𝑚"(𝑡𝑡) = '
𝑎𝑎(𝑔𝑔(𝑡𝑡") − 𝑔𝑔0)𝑙𝑙𝑔𝑔𝑙𝑙(𝑡𝑡 − 𝑡𝑡") 𝑖𝑖𝑖𝑖𝑔𝑔(𝑡𝑡") > 𝑔𝑔0
0                        𝑜𝑜𝑡𝑡ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑖𝑖𝑒𝑒𝑒𝑒
where g0 is the threshold glycemic index, and lgn(t) is the normal curve, identified by 







 The parameters of the model (i.e. a, m0, g0, m, s) were estimated using a non-linear 
fitting procedure, based on a genetic algorithm, that determines the optimal param-
eter set corresponding to the best correspondence between measured motility and the 
model output [Francia et al., 2017].
The model reproduces the physiological knowledge on the effect of an impaired 
metabolic control, assuming that such impairment requires a certain amount of time 
to develop its effects. Once mobility is reduced, even when glycemic control is total-
ly restored, the reduction lingers before the tissue can even partially recover its lost 
mobility. However, in order to reduce the number of free parameters and improve 
the stability of the numerical fitting procedure, the model assumes that if per-
fect metabolic control is re-established in the patient, his/her mobility will be fully 
restored. 
Statistical analysis
Data are reported as the mean ± standard deviation (SD) or percentage, as appro-
priate. ROM values are expressed in degree and reported as the mean ± SD. Com-
parisons between groups were analyzed by ANOVA, using the Bonferroni correction 
for multiple comparisons. Frequencies were compared using the Chi-square method. 
Multiple regression analysis was performed using the AJM as the dependent variable 
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and all variables which appeared to be significantly correlated with joint mobility as 
confounding factors for univariate analysis. A two-tailed p value <0.05 was regarded 
as statistically significant. All calculations were performed using the SPSS system for 
Windows Version 16.0 (SPSS Inc., Chicago, IL, USA).
Results
Both plantar and dorsal flexion ankle joint mobility was significantly lower in dia-
betic subjects than in controls, (p<0.001), with an average 19.6% reduction of AJM in 
diabetic patients (Table 1).
We did not find a correlation between AJM and sex, BMI or age in both patient 
and control groups.
Control subjects were further subdivided into two groups: soccer players (CC 
group) and others (volleyball players and dancers, see table 2). Among the controls, 
soccer players had more significantly reduced dorsiflexion than other group mem-
bers (p<0.001). 
The model that best describes the relationship between glycemic control impair-
ment and measured mobility corresponds to the parameter values a = 37°, m0 = 137°, 
g0 = 6.7, m = 30, s = 3.5; in this configuration the model explained about 50% of data 
variability. Furthermore, the curve describing the mobility reduction corresponds to 
the curve reported in Fig. 1. The curve has a strong similarity to expected physiologi-
cal behavior, namely that metabolic control deficit takes several months to produce its 
maximum effect.








Age (yrs) 13.8 ± 3.5 14.4 ± 3.5 NS
Gender (males/females) 31/22 22/15 –
Diabetes duration (yrs) – 7.3 ± 3.7 –
BMI (Kg/m2) 19.4 ± 3.4 20 .0±3.2 NS
Neuropathy at baseline No. (%} – 0 –
Plantar flexion (°-degree} 35.2 ± 6.5 28.5 ± 7.5 <0.001
Dorsal flexion (°) 104 .7 ± 12.8 93.9 ±16.0 <0.005
Total AJM(°) 140.0 ± 17.1 122.4 ± 20.7 <0.001
Compared to age-, BMI-and sex-matched controls . Values are mean ± SD.
*by one-way ANOVA.
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Discussion
This study indicates that our young T1DM patients had a significant reduction 
of ankle joint mobility, and associates the own AJM with the glycemic control main-
tained over the time through the definition of a mathematical model. 
Today, although limited joint mobility in diabetic patients has not been fully 
explained, it is documented that reduced glycemic control is the main causal factor of 
increased stiffness of skin, joint capsule, ligaments and tendons (Mueller et al., 1989; 
Abate et al., 2011; Rosenbloom, 2015). The widespread occurrence of LJM in diabetic 
patients, with its significant clinical implications, is also well known (Delbridge et al., 
1988). Unfortunately, LJM as a chronic complication of diabetes can be overlooked 
because it causes only a minor, although painful, disability (Benedetti and Noacco, 
1976; Mueller et al., 1989; Abate et al., 2011; Rosenbloom et al., 2015; Zimny et al., 
2015).
The assessment of joint mobility at the ankle level, in addition to providing 
important information on the DM patient’s posture, movement quality and risk of 
developing foot ulcers, (as in adults and elderly patients), can also reveal how glyce-
mic control maintenance has affected the health of the connective tissues - especially 
the periarticular ones (Mueller et al, 1989; Zimny et al., 2004; Francia et al., 2014).
Several studies on young patients with diabetes have reported and described a rela-
tionship between joint mobility deficits and the development of peripheral neuropathy 
and micro- and macrovascular complications, suggesting the presence of similar causal 
factors, in addition to stimulating physicians to be concerned about the increased risk 
of morbidity and mortality associated with LJM (Rosenbloom et al., 1981, 2015; Camp-
bell et al., 1985; Jennings et al., 1989; Lu et al., 1993; Amin et al., 2005).
Consequently, the challenge of better understanding and monitoring the different 
responses of body tissues to the metabolic changes induced by diabetes is paramount. 
This is why one of the aims of this study was to create a mathematical model useful 
in the management of young patients with T1DM.
Table 2. Main characteristics and dorsal, plantar and total AJM (expressed as degrees ) in soccer player con-








Age (yrs) 12.0 ± 0.3 15.0 ± 4.1 <0,005
Gender (males/females) 22/0 9/22 –
BMI (Kg/m2) 17.8±2.1 20.5 ± 3.7 <0,001
Plantar flexion (°-degree} 29.7 ± 4.4 39.2 ± 4.7 <0.001
Dorsal flexion (°) 98.4 ± 12.0 109.2 ± 11.4 <0.005
Total AJM(°) 128.1 ± 14.0 148.4 ± 13.9 <0.001
Values are mean± SD.
*by one-way ANOVA.
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The assessment of HbA1c values is a commonly accepted procedure for moni-
toring glycemic control in clinical settings. This parameter measures the level of 
glycosylated hemoglobin in red blood cells that is correlated to the glucose control 
achieved in the previous 3 months. It has been fully confirmed that there is a strong 
relationship between glycemic control, HbA1c assessments and the risk of develop-
ment and progression of the chronic complications induced by diabetes (Saudek and 
Brick, 2009; Rosenbloom, 2015). 
Connective tissues exhibit different rhythms of extracellular matrix protein turno-
ver. Collagen is the protein that determines the main tissue properties and its turno-
ver is particularly slow, requiring up to several years. Consequently, this protein is 
exposed for longer times to glycemia changes caused by diabetes and persists in the 
extracellular matrix of periarticular tissues instead of being ascertained by the assess-
ment of HbA1c (Snedeker and Guatieri, 2014; Rosenbloom, 2015). Therefore, we felt 
it important to define a mathematical model that could describe the relationship 
between maintained glycemic control as assessed by HbA1c and the diabetes effects 
on connective periarticular tissues through evaluation of ankle joint mobility. Our 
model assumes a linear superimposition of effects, and associates a decrease in meta-
bolic control to reduced joint mobility with a lognormal shape. The model’s param-
eters have been estimated using nonlinear fitting over a sample population.
Although the limited number of subjects in our study does not allow us to draw 
definitive conclusions, the proposed approach provides some insight into the possible 
relations between impaired metabolic control and reduced mobility. We are currently 
extending the dataset in order to perform a complete validation, possibly including 
other input data (i.e. patient age, sex, and time since disease diagnosis).
The realization of this study encountered difficulties involving direct investigation 
of the relationship between long term glycemic control and connective tissue glyco-
sylation, the relationship between LJM and the condition of connective periarticular 
tissues and, finally, to the lack of consideration of LJM in the assessment and treat-
ment of young diabetic subjects.
Ankle joint mobility reduction indicates a shift in foot plantar flexion due to the 
possible effect of diabetes on foot and leg muscle connective structures, progressing 
to a rigid foot posture in plantar flexion. Such alterations result in the inability to per-
form full ankle dorsiflexion, an impairment clearly exhibited by adult subjects with 
diabetic neuropathy and/or ankle equinus who are at risk of ulcers and an increased 
risk of falling (Salsich et al. 2000; Rao et al. 2007; Francia, 2014; Dallimore and Kamin-
ski, 2015).
This condition causes a paradoxical situation: when patients are in a non-weight-
bearing position they can have a typical rigid foot posture in plantar flexion while the 
ankle is forced in dorsiflexion when standing or during walking. 
In this study it has not been necessary to consider the aging effects on joint mobil-
ity. Interestingly, 22 soccer players in the control group had a significant reduction of 
ankle joint mobility in plantar and dorsiflexion, similar to the diabetic patients, and 
more so than the others who played volleyball or danced. This result is worthy of 
further investigation.
The understanding and direct assessment of diabetes mellitus effects on periar-
ticular connective tissues can contribute to improve treatment for patients who are 
subject to chronic complications such as those affecting the feet and vascular system. 
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Therefore, knowledge of this relationship could help to prevent diabetes effects, as 
well as provide insight into other factors having high impact on joint mobility such 
as sports like soccer, lifestyle activities or aging. These other factors could be consid-
ered in the definition of future mathematical models.
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